Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Offender Ther Comp Criminol ; 56(1): 50-60, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21518701

RESUMO

Gonadotropin-releasing hormone (GnRH) agonists, such as leuprorelin, are recommended in the patients with pedophilia at highest risk of offending. However, the cerebral mechanisms of the effects of these testosterone-decreasing drugs are poorly known. This study aimed to identify changes caused by leuprorelin in a pedophilic patient's brain responses to pictures representing children. Clinical, endocrine, and fMRI investigations were done of a man with pedophilia before leuprorelin therapy and 5 months into leuprorelin therapy. Patient was compared with an age-matched healthy control also assessed 5 months apart. Before therapy, pictures of boys elicited activation in the left calcarine fissure, left insula, anterior cingulate cortex, and left cerebellar vermis. Five months into therapy, all the above-mentioned activations had disappeared. No such activations and, consequently, no such decreases occurred in the healthy control. The results of this pilot study suggest that leuprorelin decreased activity in regions known to mediate the perceptual, motivational, and affective responses to visual sexual stimuli.


Assuntos
Nível de Alerta/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Hormônio Liberador de Gonadotropina/agonistas , Leuprolida/uso terapêutico , Imageamento por Ressonância Magnética , Pedofilia/tratamento farmacológico , Antidepressivos de Segunda Geração/uso terapêutico , Mapeamento Encefálico , Criança , Terapia Combinada , Método Duplo-Cego , Seguimentos , Humanos , Libido/efeitos dos fármacos , Masculino , Mianserina/uso terapêutico , Pessoa de Meia-Idade , Consumo de Oxigênio/efeitos dos fármacos , Projetos Piloto , Psicoterapia , Valores de Referência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...